The AG regimen is a type of chemotherapy that refers to albumin paclitaxel in combination with gemcitabine hydrochloride to treat pancreatic cancer. This approach usually only delays the disease and does not completely cure pancreatic cancer. The AG regimen involves injections of albumin paclitaxel in combination with gemcitabine hydrochloride to treat pancreatic cancer. It is usually used for patients who are unable to undergo surgery and can control the progression of the disease and relieve the adverse symptoms in the short term. This method of chemotherapy is more damaging and may be intolerant during treatment, so it is important to tailor the solution to the individual’s specific situation. If a pancreatic cancer patient’s body meets the criteria for surgery, it is recommended that surgery be performed as soon as possible to remove the diseased part of the pancreas. The disease progression is then limited by radiotherapy and chemotherapy. Secondly, pancreatic cancer can cause the body to develop nutritional absorption disorders, so it is important to give timely support with parenteral and intestinal nutritional preparations. AG program is a common treatment for pancreatic cancer, but it is not the only treatment, and it should be carried out according to the doctor’s instructions.